We first need to emphasize that both procedures, angioplasty and bypass surgery, are suitable strategies for the treatment of coronary artery disease. In choosing the best alternative to treat their condition, patients usually consult with their physician. Angioplasty is a procedure that uses endovascular techniques, that is to say, through guide wire crossing (what is<a href="https://solaci.org/en/2015/06/01/what-is-the-difference-between-a-bypass-and-angioplasty/" title="Read more" >...</a>
Angioplasty using a drug eluting balloon in the superficial femoral artery
Original title: Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease 12-Month Results From the IN.PACT SFA Randomized Trial. Reference: Gunnar Tepe et al. Circulation. 2015;131:495-502. This interesting study randomly selected 331 patients with intermittent claudication or ischemic rest pain due to stenosis of the superficial femoral artery or<a href="https://solaci.org/en/2015/04/27/angioplasty-using-a-drug-eluting-balloon-in-the-superficial-femoral-artery/" title="Read more" >...</a>
Double Anti platelet aggregation would be sufficient for six months after angioplasty in patients with stable coronary disease NSTSEACS.
Original title: 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug. Reference: Eluting Stents in Patients Nonresistant to Aspirin The Randomized, Multicenter ITALIC Trial. JACC.VOL. 65, NO. 8, 2015 Current recommendations on dual antiplatelet therapy (DAPT) are under review, particularly in acute coronary events due largely to the advent of second-generation stents. This work studied the hypothesis<a href="https://solaci.org/en/2015/03/10/double-anti-platelet-aggregation-would-be-sufficient-for-six-months-after-angioplasty-in-patients-with-stable-coronary-disease-nstseacs/" title="Read more" >...</a>
Complications of peripheral angioplasty access
Original title: Access Site Complications After Peripheral Vascular Interventions. Incidence, Predictors, and Outcomes. Reference: Daniel Ortiz et al. Circ Cardiovasc Interv. 2014 Nov 11. Epub ahead of print. Hematomas and pseudoaneurysms are the most common complications of peripheral angioplasty, though its incidence and risk factors are unclear. A retrospective analysis was performed in 22226 patients receiving peripheral<a href="https://solaci.org/en/2014/12/05/complications-of-peripheral-angioplasty-access/" title="Read more" >...</a>
Coronary angioplasty via radial access using 4 Fr introducer. Minimally invasive to the extreme.
Original title: Comparison of frequency of Radial Artery Oclusion Alter 4Fr Versus 6Fr Transradial Coronary intervention (from the Novel Angioplasty Using Coronary Accessor Trial). Reference: Satoshi Takesita, et al. Am J Cardiol 2014;113:1986-89) Since Andreas Gruentzig performed the first angioplasty, technological development has improved devices and radial access becomes more common. This procedure reduces complications, mainly bleeding. However,<a href="https://solaci.org/en/2014/06/13/coronary-angioplasty-via-radial-access-using-4-fr-introducer-minimally-invasive-to-the-extreme/" title="Read more" >...</a>
Angioplasty versus surgery in patients with critical lower limb ischemia
Original title: Comparative effectiveness of endovascular andsurgical revascularization for patients with peripheralartery disease and critical limb ischemia: Systematicreview of revascularization in critical limb ischemia. Reference: W Schuyler Jones, et al. (Am Heart J 2014; 167:167:489-498.e7) Lower limbs critical ischemia is the most severe condition of PAD. The morbidity, mortality and costs related thereto are well documented; however, the<a href="https://solaci.org/en/2014/05/14/angioplasty-versus-surgery-in-patients-with-critical-lower-limb-ischemia/" title="Read more" >...</a>
Blush reduction in a not responsible vessel is a prognostic marker in those receiving angioplasty in the culprit vessel.
Original title: Impact of Nonculprit Vessel Myocardial Perfusion on Outcomes of Patients Undergoing Percutaneos Coronary OIntervention for Acute Coronary Síndromes. Analysis From ACUITY Trial. Reference: Alexandra Lansky, et al. JAAC Cardiovascular Intervention 2014,7:266-275 In Non ST elevation Acute Coronary Syndrome (NSTE-ACS) is demonstrated that revascularization of the culprit vessel is beneficial, but strategy it is not yet clear<a href="https://solaci.org/en/2014/05/09/blush-reduction-in-a-not-responsible-vessel-is-a-prognostic-marker-in-those-receiving-angioplasty-in-the-culprit-vessel/" title="Read more" >...</a>
Angioplasty in sirolimus – eluting stent restenosis is safe and effective beyond the change of drug.
Original title: Sirolimius-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stents restenosis: Results from the ISAR-DESIRE 2 trial. Reference: Sebastian Kufner, et al. Cardiovascular Revascularization Medicine 2014, 15:69-75. DES restenosis has always generated a challenge and a puzzle when defining the strategy of revascularization by angioplasty: A quite used concept was to switch to<a href="https://solaci.org/en/2014/05/06/angioplasty-in-sirolimus-eluting-stent-restenosis-is-safe-and-effective-beyond-the-change-of-drug/" title="Read more" >...</a>
Deferred Stenting in Primary Angioplasty could reduce No Reflow Risk and Infarct Size.
Original: A Randomized Trial of Deferred Stenting versus Immediate Stenting to Prevent No-or Slow Reflow in Acute ST-Elevation Myocardial Infarction (DEFER-STEMI). Reference: David Carrick et al. J Am Coll Cardiol. 2014. Epub ahead of print. No Reflow physiopathology involves microvascular obstruction secondary to thrombus embolization, spasm or microvascular thrombosis, and happens in approximately 10% of PCI procedures. The<a href="https://solaci.org/en/2014/03/17/deferred-stenting-in-primary-angioplasty-could-reduce-no-reflow-risk-and-infarct-size/" title="Read more" >...</a>
Multivessel angioplasty in acute myocardial infarction improves prognosis
Original title: Acute multivessel revascularization improves 1 year outcomes in ST-elevation myocardial infarction. A nationwide study from AMIS plus registry. Reference: Raban Jeger, et al. International journal of Cardiology 2014;172:76-81 The presence of multiple vessel lesions is present in about 50% of patients referred for primary angioplasty. The accepted strategy is to treat the culprit artery even<a href="https://solaci.org/en/2014/03/07/multivessel-angioplasty-in-acute-myocardial-infarction-improves-prognosis/" title="Read more" >...</a>